Vistagen Therapeutics, Inc. revenue breakdown overview

Vistagen Therapeutics, Inc. revenue for the last year amounted to 486.00 k USD, the most of which — 486.00 k USD — came from its highest performing source at the moment, Pherines, the year earlier bringing 1.06 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Vistagen Therapeutics, Inc. 486.00 k USD, and the year before that — 1.06 M USD.